EGF Theramed Health Corp.
TMED
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.07% | 28.34% | -31.58% | -21.64% | -35.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.07% | 28.34% | -31.58% | -18.78% | -35.78% |
| Operating Income | -18.07% | -28.34% | 31.58% | 18.78% | 35.78% |
| Income Before Tax | 4.74% | -420.27% | 44.40% | 25.80% | 5.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.74% | -430.74% | 44.40% | 25.80% | 5.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -52.05% | 7,600.00% | -80.60% | 138.46% | 329.41% |
| Net Income | -2.53% | -376.85% | 39.35% | 29.63% | 15.93% |
| EBIT | -18.07% | -28.34% | 31.58% | 18.78% | 35.78% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00% | -369.23% | 44.19% | 35.29% | 22.22% |
| Normalized Basic EPS | -4.17% | -337.50% | 36.00% | 50.79% | 27.27% |
| EPS Diluted | 0.00% | -369.23% | 44.19% | 35.29% | 22.22% |
| Normalized Diluted EPS | -4.17% | -337.50% | 36.00% | 50.79% | 27.27% |
| Average Basic Shares Outstanding | 1.98% | 1.98% | 8.04% | 8.59% | 8.58% |
| Average Diluted Shares Outstanding | 1.98% | 1.98% | 8.04% | 8.59% | 8.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |